Cavero I, Roach A G
Br J Pharmacol. 1980 Oct;70(2):269-76. doi: 10.1111/j.1476-5381.1980.tb07932.x.
1 In intact dogs anaesthetized with pentobarbitone, clonidine (10 mug/kg, i.v.) produced a sustained decrease in heart rate. This effect was significantly smaller in vagotomized dogs in which the sympathetic drive to the heart was either left intact or experimentally created by continuous electrical stimulation of the decentralized cardioaccelerator nerve. In the latter preparation, the negative chronotropic action of clonidine was reversed by an intravenous injection of phentolamine, whereas in the former experimental situation it was antagonized only by an intravenous plus an intravertebral artery injection of phentolamine.2 In dogs with denervated hearts the tachycardia produced by electrical stimulation of the cardioaccelerator nerve was accompanied by a rise in noradrenaline overflowing into the coronary sinus plasma. Clonidine inhibited both these effects and phentolamine restored them to pre-clonidine levels.3 Clonidine decreased heart rate in dogs with an intact parasympathetically innervated heart and decentralized stellate ganglia. When the low basal heart rate of this preparation was elevated by electrical stimulation of the cardioaccelerator nerve, clonidine had a negative chronotropic effect, the degree of which was similar to that observed in intact dogs.4 Clonidine neither modified baseline heart rates of dogs with denervated hearts nor the levels of heart rate which in this preparation were reduced by a sustained electrical stimulation of the right vagus or increased by intravenous infusions of either isoprenaline or noradrenaline.5 These findings indicate that in the intact dog, bradycardia induced by clonidine resulted both from a reduction of sympathetic drive and from a concomitant increase in parasympathetic tone. The latter action did not occur at the level of cardiac neuroeffector structures since it was observed only in the presence of centrally connected vagal pathways. The inhibition of cardiac sympathetic tone was of both peripheral and central origin. Clonidine, in fact, diminished the quantity of noradrenaline overflowing into the coronary sinus plasma in cardiac denervated dogs with a tachycardia elicited by electrical stimulation of the decentralized cardioaccelerator nerve. This peripheral effect was probably due to an activation of alpha-adrenoceptors located on sympathetic nerve terminals since it was antagonized by phentolamine. However, in vagotomized dogs (intact sympathetic pathways) intravenous phentolamine failed to antagonize the heart rate effects of clonidine which were abolished by a subsequent injection of phentolamine into the vertebral artery. Thus, the clonidine-induced inhibition of both the peripheral and central sympathetic drive to the heart would appear to be mediated via alpha-adrenoceptors.
在戊巴比妥麻醉的完整犬中,可乐定(10微克/千克,静脉注射)使心率持续降低。在切断迷走神经的犬中,这种作用明显较小,在这些犬中,心脏的交感神经驱动要么保持完整,要么通过持续电刺激去神经支配的心脏加速神经来实验性地产生。在后者的制备中,静脉注射酚妥拉明可逆转可乐定的负性变时作用,而在前者的实验情况下,只有静脉注射加椎动脉注射酚妥拉明才能拮抗可乐定的负性变时作用。
在心脏去神经的犬中,电刺激心脏加速神经所产生的心动过速伴随着溢入冠状窦血浆中的去甲肾上腺素增加。可乐定抑制了这两种作用,而酚妥拉明将它们恢复到可乐定给药前的水平。
可乐定降低了具有完整副交感神经支配心脏和去神经节状神经节的犬的心率。当通过电刺激心脏加速神经使该制备的低基础心率升高时,可乐定具有负性变时作用,其程度与在完整犬中观察到的相似。
可乐定既不改变心脏去神经犬的基础心率,也不改变在该制备中通过持续电刺激右迷走神经降低或通过静脉输注异丙肾上腺素或去甲肾上腺素升高的心率水平。
这些发现表明,在完整犬中,可乐定诱导的心动过缓既源于交感神经驱动的降低,也源于副交感神经张力的同时增加。后一种作用并非发生在心脏神经效应器结构水平,因为只有在存在中枢连接的迷走神经通路时才观察到。对心脏交感神经张力的抑制既有外周起源也有中枢起源。事实上,在心脏去神经的犬中,电刺激去神经支配的心脏加速神经引起心动过速时,可乐定减少了溢入冠状窦血浆中的去甲肾上腺素量。这种外周作用可能是由于位于交感神经末梢的α-肾上腺素能受体的激活,因为它可被酚妥拉明拮抗。然而,在切断迷走神经的犬(交感神经通路完整)中,静脉注射酚妥拉明未能拮抗可乐定对心率的作用,而随后向椎动脉注射酚妥拉明可消除可乐定对心率的作用。因此,可乐定诱导的对心脏外周和中枢交感神经驱动的抑制似乎是通过α-肾上腺素能受体介导的。